{
  "symbol": "TXMD",
  "company_name": "Therapeuticsmd Inc",
  "ir_website": "https://ir.therapeuticsmd.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://ir.therapeuticsmd.com/press-releases?field_nir_news_date_value%5Bmin#views-exposed-form-widget-news-widget-news-ul",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![top banner image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaOpt.jpg)![top banner mobile image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaMobileOpt.jpg)\n\n# undefined Press Releases\n\n## Keyword Search\n\nYear None20242023202220212020201920182017201620152014201320122011\n\n2024\n\nDate | Title  \n---|---  \n11/12/24 |  [TherapeuticsMD Announces Third Quarter 2024 Financial Results](/news-releases/news-release-details/therapeuticsmd-announces-third-quarter-2024-financial-results)  \n08/12/24 |  [TherapeuticsMD Announces Second Quarter 2024 Financial Results](/news-releases/news-release-details/therapeuticsmd-announces-second-quarter-2024-financial-results)  \n05/10/24 |  [TherapeuticsMD Announces First Quarter 2024 Financial Results](/news-releases/news-release-details/therapeuticsmd-announces-first-quarter-2024-financial-results)  \n03/29/24 |  [TherapeuticsMD Announces Full Year 2023 Financial Results](/news-releases/news-release-details/therapeuticsmd-announces-full-year-2023-financial-results)\n"
        }
      ]
    },
    {
      "section_name": "Events & Presentations",
      "links": [
        {
          "title": "Events & Presentations",
          "url": "https://ir.therapeuticsmd.com/events-and-presentations/upcoming-events",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![top banner image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaOpt.jpg)![top banner mobile image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaMobileOpt.jpg)\n\n#  Events & Presentations \n\n## Upcoming Events\n\nThere are currently no events to display. \n\nI have read and agree to the [Terms of Use](https://www.therapeuticsmd.com/terms-of-use) and [Privacy Policy](https://www.therapeuticsmd.com/privacy-policy).\n"
        }
      ]
    },
    {
      "section_name": "Financial History",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://ir.therapeuticsmd.com/financial-information/sec-filings",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![top banner image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaOpt.jpg)![top banner mobile image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaMobileOpt.jpg)\n\n#  SEC Filings \n\n## SEC Filing Keyword Search\n\nGroup 3,4,5Annual FilingsCurrent ReportsMergers & AcquisitionsOtherProxy FilingsQuarterly FilingsRegistration Statements\n\nFiling year - Any -202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995\n\n- Any -\n\nItems per page 102550\n\n10\n\n[Filing date ](?items_per_page=10&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | [Form](?items_per_page=10&order=field_nir_sec_form&sort=asc \"sort by Form\") | [Description](?items_per_page=10&order=field_nir_sec_description&sort=asc \"sort by Description\") | Filing Group | View  \n---|---|---|---|---  \nNov 12, 2024 | [8-K](/sec-filings/sec-filing/8-k/0001213900-24-096804) | Report of unscheduled material events or corporate event |  Current Reports |  [0001213900-24-096804.pdf](/static-files/91361308-1016-42e8-9f19-72a1ae4426b6) [0001213900-24-096804.rtf](/static-files/25e08cb3-62bb-4b2c-b062-9eb5afc0df89) [0001213900-24-096804.xls](/static-files/363daff7-25e4-422f-af01-60180632139a) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001213900-24-096804) [View HTML](/node/15576/html)  \nNov 12, 2024 | [10-Q](/sec-filings/sec-filing/10-q/0001213900-24-096811) | Quarterly report which provides a continuing view of a company's financial position |  Quarterly Filings |  [0001213900-24-096811.pdf](/static-files/d6a33406-da72-4109-9bca-f0c3ff7397c5) [0001213900-24-096811.rtf](/static-files/2081e506-30a9-465e-a33f-727db33d7e2f) [0001213900-24-096811.xls](/static-files/ecee111e-ca23-490a-819a-64b3241b2c99) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001213900-24-096811) [View HTML](/node/15581/html)  \nNov 12, 2024 | [SC 13G](/sec-filings/sec-filing/sc-13g/0001600136-24-000007) | A statement of beneficial ownership of common stock by certain persons |  Other |  [0001600136-24-000007.pdf](/static-files/41a035ff-d69e-40f0-b745-f9d649087102) [0001600136-24-000007.rtf](/static-files/7ec62d0d-8070-4d41-b633-146b04b532f4) [0001600136-24-000007.xls](/static-files/7eb4f7ae-59e0-4378-820a-2ecfbb00877e) [View HTML](/node/15586/html)  \nOct 25, 2024 | [DEFA14A](/sec-filings/sec-filing/defa14a/0001213900-24-090850) | Additional proxy soliciting materials - definitive |  Proxy Filings |  [0001213900-24-090850.pdf](/static-files/15184474-2030-4a2c-9715-a4d90b47e037) [0001213900-24-090850.rtf](/static-files/ffb2cf4c-e360-4f5e-a48e-af523cc644e1) [0001213900-24-090850.xls](/static-files/4c4f1408-3011-4a61-af64-c33fea57a66b) [View HTML](/node/15556/html)  \nOct 25, 2024 | [DEF 14A](/sec-filings/sec-filing/def-14a/0001213900-24-090849) | Official notification to shareholders of matters to be brought to a vote (\"Proxy\") |  Proxy Filings |  [0001213900-24-090849.pdf](/static-files/5f204e21-d0fa-4dab-8fad-0662fe47caf0) [0001213900-24-090849.rtf](/static-files/03ea2b0c-5991-4319-9ea7-ce75e790d65a) [0001213900-24-090849.xls](/static-files/06254cbe-749d-456b-8e26-3a6ace8fead2) [View HTML](/node/15561/html)  \nOct 25, 2024 | [ARS](/sec-filings/sec-filing/ars/0001213900-24-090852) | An annual report to security holders |  Annual Filings |  [0001213900-24-090852.pdf](/static-files/7084d891-8eab-4315-b27b-6e610c558ad9) [0001213900-24-090852.rtf](/static-files/6f84f68c-b56a-4968-bdc8-9dbae6659fd9) [View HTML](/node/15566/html)  \nSep 20, 2024 | [8-K](/sec-filings/sec-filing/8-k/0001213900-24-080719) | Report of unscheduled material events or corporate event |  Current Reports |  [0001213900-24-080719.pdf](/static-files/17854ba1-3ce2-4540-b799-a4ce168e83f3) [0001213900-24-080719.rtf](/static-files/e38bdc70-bf66-41f9-80e4-047edb659290) [0001213900-24-080719.xls](/static-files/66065895-4866-49d9-93d0-9246f8eb5129) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001213900-24-080719) [View HTML](/node/15551/html)  \nAug 26, 2024 | [4](/sec-filings/sec-filing/4/0000905148-24-002363) | Statement of changes in beneficial ownership of securities |  3,4,5 |  [0000905148-24-002363.pdf](/static-files/57b27731-ca41-4e03-927c-fa1b02c0f362) [0000905148-24-002363.rtf](/static-files/e2835679-8274-43fe-b3e5-ffd5ded73bc1) [0000905148-24-002363.xls](/static-files/018e18bd-c474-4301-88d5-bd6d840d1d0c) [View HTML](/node/15546/html)  \nAug 23, 2024 | [4](/sec-filings/sec-filing/4/0000905148-24-002340) | Statement of changes in beneficial ownership of securities |  3,4,5 |  [0000905148-24-002340.pdf](/static-files/bdeadc35-1e78-4e06-9dae-41bec4ad5b90) [0000905148-24-002340.rtf](/static-files/5386dc14-ed2d-4ebf-a99c-672c2d82e191) [0000905148-24-002340.xls](/static-files/4dc382db-58f4-4e50-b73a-1a134ab6cde1) [View HTML](/node/15541/html)  \nAug 12, 2024 | [8-K](/sec-filings/sec-filing/8-k/0001213900-24-067670) | Report of unscheduled material events or corporate event |  Current Reports |  [0001213900-24-067670.pdf](/static-files/012ac1b8-50a4-4f55-be65-5651c63f0692) [0001213900-24-067670.rtf](/static-files/8c3b6f11-f949-4d64-87d0-8c554bafa255) [0001213900-24-067670.xls](/static-files/5401dcef-01c7-4425-8aa5-e101c5d919da) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/8-k/0001213900-24-067670) [View HTML](/node/15531/html)  \n  \nDisplaying 1 - 10 of 1131 results\n\nData provided by [Kaleidoscope](https://www.kscope.io).\n"
        }
      ]
    },
    {
      "section_name": "SEC Filings",
      "links": [
        {
          "title": "Annual Reports",
          "url": "https://ir.therapeuticsmd.com/financial-information/annual-reports",
          "content": "[ Skip to main navigation ](#main-menu)\n\n![top banner image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaOpt.jpg)![top banner mobile image](/sites/g/files/knoqqb11286/themes/site/nir_pid1050/client/images/TXMDCorporateBanners_InvestorsandMediaMobileOpt.jpg)\n\n#  Financial Reports \n\nFiling date  | Form | Description | Filing Group | View  \n---|---|---|---|---  \nNov 12, 2024 | [10-Q](/sec-filings/sec-filing/10-q/0001213900-24-096811) | Quarterly report which provides a continuing view of a company's financial position |  Quarterly Filings | [View HTML](/node/15581/html) [0001213900-24-096811.pdf](/static-files/d6a33406-da72-4109-9bca-f0c3ff7397c5) [0001213900-24-096811.rtf](/static-files/2081e506-30a9-465e-a33f-727db33d7e2f) [0001213900-24-096811.xls](/static-files/ecee111e-ca23-490a-819a-64b3241b2c99) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001213900-24-096811)  \nOct 25, 2024 | [ARS](/sec-filings/sec-filing/ars/0001213900-24-090852) | An annual report to security holders |  Annual Filings | [View HTML](/node/15566/html) [0001213900-24-090852.pdf](/static-files/7084d891-8eab-4315-b27b-6e610c558ad9) [0001213900-24-090852.rtf](/static-files/6f84f68c-b56a-4968-bdc8-9dbae6659fd9)  \nAug 12, 2024 | [10-Q](/sec-filings/sec-filing/10-q/0001213900-24-067771) | Quarterly report which provides a continuing view of a company's financial position |  Quarterly Filings | [View HTML](/node/15536/html) [0001213900-24-067771.pdf](/static-files/283fa1d6-9376-43f0-ad54-0335b4609cce) [0001213900-24-067771.rtf](/static-files/684035b5-3eac-49c1-b43a-7c7b7151c819) [0001213900-24-067771.xls](/static-files/7d17a26f-1547-4381-ae13-7bf95b39854b) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001213900-24-067771)  \nMay 10, 2024 | [10-Q](/sec-filings/sec-filing/10-q/0001213900-24-041738) | Quarterly report which provides a continuing view of a company's financial position |  Quarterly Filings | [View HTML](/node/15516/html) [0001213900-24-041738.pdf](/static-files/f404516c-259f-4a0f-8bb1-106240b75c60) [0001213900-24-041738.rtf](/static-files/9a350828-f5f9-4c6b-a58a-2d8134643b98) [0001213900-24-041738.xls](/static-files/ae7db5b2-4949-4c83-a202-5b5a0d741f20) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0001213900-24-041738)  \nApr 29, 2024 | [10-K/A](/sec-filings/sec-filing/10-ka/0001213900-24-037258) | Amendment to a previously filed 10-K |  Annual Filings | [View HTML](/node/15501/html) [0001213900-24-037258.pdf](/static-files/c05f4437-654d-49b1-8f00-caaa5dde1ba7) [0001213900-24-037258.rtf](/static-files/d294eff8-c050-4ebe-abeb-3568db6e8e1d) [0001213900-24-037258.xls](/static-files/e5017b15-215f-40e0-b10d-55d53903b244) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-ka/0001213900-24-037258)\n"
        }
      ]
    }
  ]
}